In the last weeks we have seen in Flanders numerous initiatives to respond to the COVID‐19 crisis, many of them arising bottom‐up, often in collaboration with European partnerships that received funding from the European Union’s Horizon 2020 research and innovation programme. Everywhere in the region, research groups, as well as companies, have reallocated budgets to address different issues related to the COVID‐19 pandemic. The Flemish universities and their experts play a crucial role in the guidance and decisionmaking of this unseen crisis. This is particularly challenging, as the virus is new and its pathophysiology, the epidemiology and social impact need to be better understood to develop better diagnostics, vaccines, treatments and interventions. [...]
About Annelies DebucquoyThis author has not yet filled in any details.
So far Annelies Debucquoy has created 32 blog entries.
On November 4th, the Belgian Biobanking Day was organized by BBMRI.be and Greiner. We would like to thank all speakers and attendants of the meeting, to make this day [...]
The Royal Decree of 9 January 2018 on biobanks, published in the Belgian Official Gazette on 05.02.2018 in implementation of Article 22 of the Law of 19 December 2008 [...]
If you use human samples or human cell lines for your research, you’ll need to register your organisation as an official BIOBANK with FAMHP. What are the different steps? [...]
To facilitate the implementation of the Belgian royal decree on biobanks (9/01/2018), the Federal Agency for Medicines and Health Products (FAMHP/FAGG/AFMPS) set up a working group with representatives from academic [...]